key: cord-0735128-35gspp91
authors: Coronado-Arroyo, Julia Cristina; Concepción-Zavaleta, Marcio José; Zavaleta-Gutiérrez, Francisca Elena; Concepción-Urteaga, Luis Alberto
title: Is COVID-19 a risk factor for severe preeclampsia? Hospital experience in a developing country
date: 2020-09-14
journal: Eur J Obstet Gynecol Reprod Biol
DOI: 10.1016/j.ejogrb.2020.09.020
sha: 587e4260148d42498debf5bd84752ea53b4b0f97
doc_id: 735128
cord_uid: 35gspp91

nan

. Eleven patients were pregnant at term, and there was only one twin pregnancy. Regarding the respiratory symptoms, 16/20 (80%) patients were asymptomatic, with the remaining patients exhibiting mild symptoms. The most frequent findings in their laboratory tests were as follows: hypertransaminasemia, 40%-65%; leukocytosis, 30%; lymphopenia, 15%; and elevated C-reactive protein levels, 10%. Of all the patients, 15% (3/20) met the criteria for gestational hypertension and 15% (3/20) met the criteria for preeclampsia without signs of severity, whereas 70% (14/20) met the criteria for severe hypertensive disorders of pregnancy, comprising nine patients with severe preeclampsia; two with eclampsia; and five with hemolysis, elevated liver enzymes and low platelet count syndrome. The main route of delivery was cesarean section, which was performed in 85% (17/20) patients; one hysterectomy was performed for placenta accreta. The fetal death rate was 9.5% (2/20). Furthermore, 71% of the newborns had appropriate weight for their gestational age and 9.5% were small for gestational age. Only one newborn tested positive in the nasopharyngeal swab test for SARS-CoV-2 within the first 24 hours of life.

In conclusion, based on these preliminary findings, we suggest that SARS-CoV-2 infection, by inducing a pro-inflammatory state, predisposes pregnant women to a greater severity of the course of preeclampsia, even when severe respiratory symptoms are absent. We suggest the need for more scientific evidence to confirm this possible association.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

COVID-19 infection: ACE2, pregnancy and preeclampsia

Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (80-) 2020

Severe pre-eclampsia complicated by acute fatty liver disease of pregnancy, HELLP syndrome and acute kidney injury following SARS-CoV-2 infection

Placental Pathology in COVID-19

Características maternoperinatales de gestantes COVID-19 en un hospital nacional de Lima